Cargando…
IL-10 Blocks the Development of Resistance to Re-Infection with Schistosoma mansoni
Despite effective chemotherapy to treat schistosome infections, re-infection rates are extremely high. Resistance to reinfection can develop, however it typically takes several years following numerous rounds of treatment and re-infection, and often develops in only a small cohort of individuals. Us...
Autores principales: | Wilson, Mark S., Cheever, Allen W., White, Sandra D., Thompson, Robert W., Wynn, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150278/ https://www.ncbi.nlm.nih.gov/pubmed/21829367 http://dx.doi.org/10.1371/journal.ppat.1002171 |
Ejemplares similares
-
Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human Schistosoma mansoni Infection
por: Franco, Karine Garcez Schuster, et al.
Publicado: (2021) -
Schistosoma mansoni Tegument (Smteg) Induces IL-10 and Modulates Experimental Airway Inflammation
por: Marinho, Fábio Vitarelli, et al.
Publicado: (2016) -
Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021) -
Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018) -
Schistosoma mansoni egg-derived thioredoxin and Sm14 drive the development of IL-10 producing regulatory B cells
por: Chayé, Mathilde A. M., et al.
Publicado: (2023)